Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition(EMBO Mol Med., (2023), 15, (e17719), 10.15252/emmm.202317719)

Sarah Proteau; Imène Krossa; Chrystel Husser; Maxime Guéguinou; Federica Sella; Karine Bille; Marie Irondelle; Mélanie Dalmasso; Thibault Barouillet; Yann Cheli; Céline Pisibon; Nicole Arrighi; Sacha Nahon-Estève; Arnaud Martel; Lauris Gastaud; Sandra Lassalle; Olivier Mignen; Patrick Brest; Nathalie M. Mazure; Frédéric Bost; Stéphanie Baillif; Solange Landreville; Simon Turcotte; Dan Hasson; Saul Carcamo; Christophe Vandier; Emily Bernstein; Laurent Yvan-Charvet; Mitchell P. Levesque; Robert Ballotti; Corine Bertolotto; Thomas Strub

doi:10.1038/s44321-024-00114-1

Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition(EMBO Mol Med., (2023), 15, (e17719), 10.15252/emmm.202317719)

Sarah Proteau, Imène Krossa, Chrystel Husser, Maxime Guéguinou, Federica Sella, Karine Bille, Marie Irondelle, Mélanie Dalmasso, Thibault Barouillet, Yann Cheli, Céline Pisibon, Nicole Arrighi, Sacha Nahon-Estève, Arnaud Martel, Lauris Gastaud, Sandra Lassalle, Olivier Mignen, Patrick Brest, Nathalie M. Mazure, Frédéric BostStéphanie Baillif, Solange Landreville, Simon Turcotte, Dan Hasson, Saul Carcamo, Christophe Vandier, Emily Bernstein, Laurent Yvan-Charvet, Mitchell P. Levesque, Robert Ballotti, Corine Bertolotto, Thomas Strub

Research output: Contribution to journal › Comment/debate

Abstract

During the publication proofing process, the author identified several formatting errors. These errors were not corrected by the publisher prior to the release of the publication. These errors are now corrected.

Original language	English
Pages (from-to)	2262-2267
Number of pages	6
Journal	EMBO Molecular Medicine
Volume	16
Issue number	9
DOIs	https://doi.org/10.1038/s44321-024-00114-1
State	Published - 12 Sep 2024

Access to Document

10.1038/s44321-024-00114-1

Cite this

Proteau, S., Krossa, I., Husser, C., Guéguinou, M., Sella, F., Bille, K., Irondelle, M., Dalmasso, M., Barouillet, T., Cheli, Y., Pisibon, C., Arrighi, N., Nahon-Estève, S., Martel, A., Gastaud, L., Lassalle, S., Mignen, O., Brest, P., Mazure, N. M., ... Strub, T. (2024). Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition(EMBO Mol Med., (2023), 15, (e17719), 10.15252/emmm.202317719). EMBO Molecular Medicine, 16(9), 2262-2267. https://doi.org/10.1038/s44321-024-00114-1

@article{1ad6171d963b4328b38e2267d16d8b55,

title = "Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition(EMBO Mol Med., (2023), 15, (e17719), 10.15252/emmm.202317719)",

abstract = "During the publication proofing process, the author identified several formatting errors. These errors were not corrected by the publisher prior to the release of the publication. These errors are now corrected.",

author = "Sarah Proteau and Im{\`e}ne Krossa and Chrystel Husser and Maxime Gu{\'e}guinou and Federica Sella and Karine Bille and Marie Irondelle and M{\'e}lanie Dalmasso and Thibault Barouillet and Yann Cheli and C{\'e}line Pisibon and Nicole Arrighi and Sacha Nahon-Est{\`e}ve and Arnaud Martel and Lauris Gastaud and Sandra Lassalle and Olivier Mignen and Patrick Brest and Mazure, {Nathalie M.} and Fr{\'e}d{\'e}ric Bost and St{\'e}phanie Baillif and Solange Landreville and Simon Turcotte and Dan Hasson and Saul Carcamo and Christophe Vandier and Emily Bernstein and Laurent Yvan-Charvet and Levesque, {Mitchell P.} and Robert Ballotti and Corine Bertolotto and Thomas Strub",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

year = "2024",

month = sep,

day = "12",

doi = "10.1038/s44321-024-00114-1",

language = "English",

volume = "16",

pages = "2262--2267",

journal = "EMBO Molecular Medicine",

issn = "1757-4676",

publisher = "Wiley-Blackwell",

number = "9",

}

Proteau, S, Krossa, I, Husser, C, Guéguinou, M, Sella, F, Bille, K, Irondelle, M, Dalmasso, M, Barouillet, T, Cheli, Y, Pisibon, C, Arrighi, N, Nahon-Estève, S, Martel, A, Gastaud, L, Lassalle, S, Mignen, O, Brest, P, Mazure, NM, Bost, F, Baillif, S, Landreville, S, Turcotte, S, Hasson, D, Carcamo, S, Vandier, C, Bernstein, E, Yvan-Charvet, L, Levesque, MP, Ballotti, R, Bertolotto, C & Strub, T 2024, 'Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition(EMBO Mol Med., (2023), 15, (e17719), 10.15252/emmm.202317719)', EMBO Molecular Medicine, vol. 16, no. 9, pp. 2262-2267. https://doi.org/10.1038/s44321-024-00114-1

Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition(EMBO Mol Med., (2023), 15, (e17719), 10.15252/emmm.202317719). / Proteau, Sarah; Krossa, Imène; Husser, Chrystel et al.
In: EMBO Molecular Medicine, Vol. 16, No. 9, 12.09.2024, p. 2262-2267.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Publisher Correction

T2 - LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition(EMBO Mol Med., (2023), 15, (e17719), 10.15252/emmm.202317719)

AU - Proteau, Sarah

AU - Krossa, Imène

AU - Husser, Chrystel

AU - Guéguinou, Maxime

AU - Sella, Federica

AU - Bille, Karine

AU - Irondelle, Marie

AU - Dalmasso, Mélanie

AU - Barouillet, Thibault

AU - Cheli, Yann

AU - Pisibon, Céline

AU - Arrighi, Nicole

AU - Nahon-Estève, Sacha

AU - Martel, Arnaud

AU - Gastaud, Lauris

AU - Lassalle, Sandra

AU - Mignen, Olivier

AU - Brest, Patrick

AU - Mazure, Nathalie M.

AU - Bost, Frédéric

AU - Baillif, Stéphanie

AU - Landreville, Solange

AU - Turcotte, Simon

AU - Hasson, Dan

AU - Carcamo, Saul

AU - Vandier, Christophe

AU - Bernstein, Emily

AU - Yvan-Charvet, Laurent

AU - Levesque, Mitchell P.

AU - Ballotti, Robert

AU - Bertolotto, Corine

AU - Strub, Thomas

PY - 2024/9/12

Y1 - 2024/9/12

N2 - During the publication proofing process, the author identified several formatting errors. These errors were not corrected by the publisher prior to the release of the publication. These errors are now corrected.

AB - During the publication proofing process, the author identified several formatting errors. These errors were not corrected by the publisher prior to the release of the publication. These errors are now corrected.

UR - http://www.scopus.com/inward/record.url?scp=85201661516&partnerID=8YFLogxK

U2 - 10.1038/s44321-024-00114-1

DO - 10.1038/s44321-024-00114-1

M3 - Comment/debate

AN - SCOPUS:85201661516

SN - 1757-4676

VL - 16

SP - 2262

EP - 2267

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

IS - 9

ER -

Publisher Correction: LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition(EMBO Mol Med., (2023), 15, (e17719), 10.15252/emmm.202317719)

Abstract

Access to Document

Fingerprint

Cite this